Telecom Stocks Slide as SpaceX Spectrum Deal Sparks Competition Fears
US and European telecommunications stocks tumbled on Friday after SpaceX’s acquisition of low-band spectrum intensified concerns over competition from satellite-based mobile services. T-Mobile US, Verizon and AT&T fell between 5.5% and 7.4% in premarket...
Netflix Reportedly Plans to Cut 5% of Its Workforce
Netflix is planning to cut approximately 5% of its workforce, with an announcement expected as early as next week, according to a report by Puck News on Friday, citing people familiar with the matter....
WTO Raises Global Trade Forecast as AI Boom Offsets Middle East Disruptions
The World Trade Organization has upgraded its forecast for global merchandise trade growth in 2026 to 3.9%, more than double its previous estimate of 1.9%. The stronger outlook reflects robust demand for semiconductors and...
Goldman Sachs Executives Set for Over $500 Million in Special Awards
Goldman Sachs Group’s top executives are set to receive special equity awards worth more than $500 million, Bloomberg News reported on Wednesday. The awards, granted in October 2021, were disclosed by Goldman in various...
GlobalFoundries Signs $2 Billion TSMC AI Chip Deal
GlobalFoundries said on Thursday it has reached a $2 billion, five-year agreement to manufacture silicon interposers for TSMC at its facility in Malta, New York. Silicon interposers are critical components used in advanced AI...
BBC and Channel 4 Explore Deeper Tie-Up to Cut Costs
Britain’s BBC and Channel 4 have held preliminary talks with the government about a broader tie-up of some operations, potentially reshaping the country’s public broadcasting landscape. One proposal would combine Channel 4’s advertising operations,...
Amazon Unveils Premium Android Tablets With Alexa+ AI
Amazon has unveiled a new range of higher-end tablets that run on Google’s Android operating system and feature its AI-powered Alexa+ voice assistant. The new Alexa Tablets start at $230 and go up to...
AI Simulations Aim to Predict Drug Trial Failures
Artificial intelligence is emerging as a potential tool to help pharmaceutical companies predict whether experimental drugs are likely to succeed before costly human trials. Novartis shares fell 11% after its late-stage trial of experimental...












